294 pharma firms avail of tech upgradation subsidy

Companies have utilised about 20 cr for the purpose

Image
Press Trust of India New Delhi
Last Updated : Jan 20 2013 | 3:24 AM IST

The Government today said as many as 294 micro and small pharmaceuticals companies have availed of a subsidy of nearly Rs 19.76 crore for technology upgradation under the credit linked capital subsidy scheme (CLCSS).

"Under this scheme 294 drugs and pharmaceuticals micro and small enterprises have availed subsidy of about Rs 19.76 crore since inception of the CLCSS up to March, 2012," Minister of State for Chemical and Fertilisers Srikant Kumar Jena said in a written reply to the Lok Sabha.

He said said the Ministry of Micro, Small and Medium Enterprises is implementing the CLCSS to provide incentives to micro and small enterprises including drug and pharmaceuticals for technology upgradation.

"Under this scheme 15% capital subsidy is provided up to a loan of Rs 1 crore as per the guidelines of the scheme," Jena said.

The policy is being implemented for 48 sub-sectors including the drugs and pharmaceuticals sub-sector, he added.

In reply to a question, the Minister said upgradation helps companies to improve their quality standards though it may not necessarily bring down the prices.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Apr 26 2012 | 3:01 PM IST

Next Story